CronusChemicals is the new name for a chemical that was created in Australia by the Indian company, Chemicals India.
Cronuschemicals is a chemical used in the manufacturing of plastics and other consumer goods.
In addition to being used in many products, it is also found in cosmetics, household cleaners and disinfectants.
But this is where things get a bit more complicated.
According to Cronus chemical news website, the company claims that Cronus has invented an anti-cancer drug that is “faster and more effective than existing chemotherapy drugs”.
Cronuschemicalnews.com.au reports that the company is developing its own version of Cronus chemicals called Cronus (pronounced KORN-sen) and claims to have developed it in partnership with the Indian government.
The drug, which is expected to be released within months, is said to be “the most powerful, efficient and most cost-effective drug ever developed by a pharmaceutical company”.
The company is reportedly working on a clinical trial of its Cronus drug in India and plans to begin a global phase-three clinical trial in 2019.
The company also plans to develop a version of the Cronus compound that has “no side effects”, according to the company.
It is believed that the drug is meant to be a safer alternative to chemotherapy drugs in that it does not contain any cancer-causing chemicals, and is only meant to treat cancers of the skin, stomach, liver, heart, kidneys, lungs, pancreas and brain.
However, the Cronuss drug is still not completely tested in humans and so its safety remains unclear.
According the website, Cronus is “a safer alternative for cancer treatment”, which means that the drugs effectiveness is based on a number of factors.
One of those factors is the amount of chemicals involved in the drug.
According Cronus, the drugs active ingredients are derived from a mixture of chemical compounds.
“A number of different compounds are present in the formulation of the drug, such as the natural peptide hydroxyethyl starch, polysaccharides, alkaloids, and terpenes, as well as amino acids and other ingredients in foods and food-related supplements,” Cronus said.
The chemical structure of Cronuss is complex and not exactly easy to understand.
Cronuss chemicals contain several active ingredients.
The active ingredients in Cronus include: cyclopropane glycol, d-methoxyethanol, cyclohexanone, cyclobutanol, ethylhexylglycerin, polycyclic aromatic hydrocarbons, and di-cyclohexane-1-yl acetate.
The website claims that the ingredients in the Cronusk are derived “from the natural components of the plant, and are free of any known harmful substances”.
Cronusschemicalnews, a Cronus company spokesperson told The Hindu that “The chemicals in the pharmaceutical industry have changed in the last 20 years, with the use of newer synthetic compounds, which may be less effective and have higher toxicity than their natural counterparts”.
“The drugs are tested in animal studies, and the FDA has approved the drugs to treat cancer and a number other conditions.”
In a press release, the website claimed that “the Cronuss compound has been shown to have a remarkable anti-tumor activity and has been clinically tested in several animal models”.
The release also stated that “clinical trials are underway in several clinical trials, including the phase III trial in India, to determine whether the Cronuses anti-molecular, chemotherapeutic and anticancer properties will be as promising as those of the existing chemotherapy and radiotherapy drugs”.
The website also claims that it is “in discussions with a number companies in India to manufacture the Cronuzone compound in India.”
Cronus chemotherapists also claim that Cronuss compounds are safe and that the FDA will be following up with the company on whether its Cronuss drugs are safe.
According The Hindu, Cronuss chemotherapist Dr Rishi Narain told the website that Cronum is being developed “with the support of the government of India, as a safer, faster and more efficient alternative to existing chemotherapy treatments”.
Narain said that Cronuzones “anti-cancer properties are much better than chemotherapy drugs and will be able to treat many different types of cancers, such the tumours of the stomach, the pancreases, breast and brain”.
The Cronus product is also being tested in India as well.
According To The Hindu Cronus was initially tested on humans in a clinical study in India in 2013 and a phase III clinical trial was started in 2018.
According a spokesperson for the company, “The clinical trial is being carried out at the Centre for Biological Sciences at the University of New South Wales.
The trial will be carried out under an accelerated testing scheme, which will provide the company with the highest safety profile.”